{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:53:26Z","timestamp":1778000006745,"version":"3.51.4"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian Pediatr"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s13312-017-1156-5","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T04:08:01Z","timestamp":1508818081000},"page":"885-886","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mycophenolate sodium for children with frequently relapsing or steroid dependent nephrotic syndrome"],"prefix":"10.1007","volume":"54","author":[{"given":"Kanika","family":"Kapoor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijeet","family":"Saha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nand Kishore","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish Datt","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,25]]},"reference":[{"key":"1156_CR1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00007691-199512000-00023","volume":"17","author":"JT Ransom","year":"1995","unstructured":"Ransom JT. Mechanism of action of mycophenolate mofetil. Therap Drug Monit. 1995;17:68\u201384.","journal-title":"Therap Drug Monit."},{"key":"1156_CR2","first-page":"140","volume":"16","author":"M Zolezzi","year":"2005","unstructured":"Zolezzi M. Mycophenolate sodium versus mycophenolate mofetil: A review of their comparative features. Saudi J Kidney Dis Transplant. 2005;16:140\u20135.","journal-title":"Saudi J Kidney Dis Transplant."},{"key":"1156_CR3","first-page":"203","volume":"45","author":"Indian Pediatrics Nephrology Group","year":"2008","unstructured":"Indian Pediatrics Nephrology Group, Indian Academy of Pediatrics Management of steroid sensitive nephrotic syndrome: Revised guidelines. Indian Pediatr. 2008;45:203\u201314.","journal-title":"Indian Pediatr"},{"key":"1156_CR4","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/j.ajkd.2003.08.011","volume":"42","author":"A Bagga","year":"2003","unstructured":"Bagga A, Hari P, Moudgil A, Jordan SC. Mycophenolate mofetil and prednisolone therapy in children with steroiddependent nephrotic syndrome. Am J Kidney Dis. 2003;42:1114\u201320.","journal-title":"Am J Kidney Dis."},{"key":"1156_CR5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00467-012-2278-6","volume":"28","author":"S Banerjee","year":"2013","unstructured":"Banerjee S, Pahari A, Sengupta J, Patnaik SK. Outcome of severe steroid-dependent nephrotic syndrome treated with mycophenolate mofetil. Pediatr Nephrol. 2013;28:93\u20137.","journal-title":"Pediatr Nephrol."},{"key":"1156_CR6","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00467-007-0617-9","volume":"22","author":"K Afzal","year":"2007","unstructured":"Afzal K, Bagga A, Menon S, Hari P, Jordan SC. Treatment with mycophenolate mofetil and prednisolone for steroiddependent nephrotic syndrome. Pediatr Nephrol. 2007;22:2059\u201365.","journal-title":"Pediatr Nephrol."},{"key":"1156_CR7","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2215\/CJN.00550206","volume":"1","author":"RJ Hogg","year":"2006","unstructured":"Hogg RJ, Fitzgibbons L, Bruick J, Bunke M, Ault B, Baqi N, et al. Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: A Report from the southwest pediatric nephrology study group. Clin J Am Soc Nephrol. 2006;1:1173\u20138.","journal-title":"Clin J Am Soc Nephrol."},{"key":"1156_CR8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1600-6143.2003.00337.x","volume":"4","author":"M Salvadori","year":"2004","unstructured":"Salvadori M, Holzer H, de Mattos A, Sollinger H, Arns W, Oppenheimer F, et al. Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renaltransplant patients. Am J Transplant. 2004;4:231\u20136.","journal-title":"Am J Transplant."}],"container-title":["Indian Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-017-1156-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13312-017-1156-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-017-1156-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T04:10:04Z","timestamp":1508818204000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13312-017-1156-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":8,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["1156"],"URL":"https:\/\/doi.org\/10.1007\/s13312-017-1156-5","relation":{},"ISSN":["0019-6061","0974-7559"],"issn-type":[{"value":"0019-6061","type":"print"},{"value":"0974-7559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}